{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:13Z","timestamp":1760188513344},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf01834382","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T14:26:51Z","timestamp":1119968811000},"page":"71-74","source":"Crossref","is-referenced-by-count":15,"title":["High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma"],"prefix":"10.1007","volume":"70","author":[{"given":"R.","family":"Willemze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M. J. M.","family":"Zijlmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"den Ottolander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H. F.","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W. J.","family":"Starrenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"van der Burgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. E.","family":"Fibbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01834382_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/bjc.1990.228","volume":"62","author":"AZS Rohatiner","year":"1990","unstructured":"Rohatiner AZS, Bassan R, Battista R, et al. (1990) High-dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer 62:54","journal-title":"Br J Cancer"},{"key":"BF01834382_CR2","first-page":"86","volume":"14","author":"WG Peters","year":"1987","unstructured":"Peters WG, Willemze R, Colly LP (1987) Intermediate- and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukaemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature. Semin Oncol 14:86","journal-title":"Semin Oncol"},{"key":"BF01834382_CR3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O","volume":"44","author":"S Rudnick","year":"1979","unstructured":"Rudnick S, Cadman E, Capizzi RL, Skeel RT, Bertino JR, McIntosh S (1979) High-dose cytosine arabinoside (HDARAC) in refractory acute leukaemia. Cancer 44:1189","journal-title":"Cancer"},{"key":"BF01834382_CR4","first-page":"90","volume":"12","author":"AZS Rohatiner","year":"1984","unstructured":"Rohatiner AZS, Slevin ML, Shaliwahl HS, Malpas JS, Lister TA (1984) High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 12:90","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF01834382_CR5","first-page":"73","volume":"14","author":"W Hiddemann","year":"1987","unstructured":"Hiddemann W, Kreutzman H, Straif K et al. (1987) Highdose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukaemia. Semin Oncol 14:73","journal-title":"Semin Oncol"},{"key":"BF01834382_CR6","first-page":"210","volume":"28","author":"S Amadori","year":"1987","unstructured":"Amadori S, Testi AM, Meloni G et al. (1987) High-dose AraC and idarubicin for the treatment of advanced lymphocytic leukaemia (ALL). Proc Am Assoc Cancer Res 28:210","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF01834382_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.V62.2.361.361","volume":"62","author":"RH Herzig","year":"1983","unstructured":"Herzig RH, Wolff S, Lazarus HM, Phillips GL, Karanes C, Herzig GP (1983) High-dose cytosine arabinoside therapy for refractory leukemia. Blood 62:361","journal-title":"Blood"},{"issue":"Suppl 4","key":"BF01834382_CR8","first-page":"84","volume":"28","author":"D Hoelzer","year":"1991","unstructured":"Hoelzer D (1991) High-dose chemotherapy in adult acute lymphoblastic leukemia. Semin Hematol 28 [Suppl 4]: 84\u201398","journal-title":"Semin Hematol"},{"issue":"Suppl 2","key":"BF01834382_CR9","first-page":"199","volume":"6","author":"P Stryckmans","year":"1992","unstructured":"Stryckmans P, De Witte T, Marie JP et al. (1992) Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 & ALL-3). Leukemia 6 [Suppl 2]: 199\u2013203","journal-title":"Leukemia"},{"key":"BF01834382_CR10","first-page":"67","volume":"14","author":"P Stryckmans","year":"1987","unstructured":"Stryckmans P, de Witte T, Bitar N et al. (1987) Cytosine ambinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukaemia. Semin Oncol 14:67","journal-title":"Semin Oncol"},{"key":"BF01834382_CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V46.6.823.823","volume":"46","author":"R Willemze","year":"1975","unstructured":"Willemze R, Hillen H, Hartgrink-Groeneveld CA, Haanen C (1975) Treatment of acute lymphoblastic leukaemia in adolescents and adults: a retrospective study of 41 patients (1970\u20131973). Blood 46:823","journal-title":"Blood"},{"key":"BF01834382_CR12","first-page":"160","volume":"12","author":"B Clarkson","year":"1985","unstructured":"Clarkson B, Ellis S, Little C et al. (1985) Acute lymphoblastic leukemia in adults. Semin Oncol 12:160\u2013179","journal-title":"Semin Oncol"},{"issue":"Suppl 2","key":"BF01834382_CR13","first-page":"175","volume":"6","author":"D Hoelzer","year":"1992","unstructured":"Hoelzer D, Thiel E, Ludwig WD et al. (1992) The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia 6 [Suppl 2]: 175\u2013177","journal-title":"Leukemia"},{"key":"BF01834382_CR14","first-page":"197","volume-title":"Acute lymphoblastic leukemia","author":"PA Cassileth","year":"1990","unstructured":"Cassileth PA, Andersen JW, Hoagland HC et al. (1990) Highdose cytarabine therapy in adult acute lymphocytic leukemia. In: Gale RP, Hoelzer D (eds) Acute lymphoblastic leukemia. Liss, New York, p 197"},{"key":"BF01834382_CR15","unstructured":"Boogaerts MA, Emonds MP, Kennes C et al. (1987) Intensive consolidation and maintenance therapy for acute lymphoblastic leukemia in adults. 4th International Symposium on Therapy of Acute Leukemias. Rome, p 442"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01834382.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01834382\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01834382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T01:02:36Z","timestamp":1586307756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01834382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF01834382"],"URL":"https:\/\/doi.org\/10.1007\/bf01834382","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}